Los Angeles Allergist

Los Angeles Allergist

Alan Khadavi, MD, APC
  • Home
  • Meet Dr. Khadavi
  • Conditions We Treat
  • Your First Visit
  • Insurance Accepted
  • Allergy and Asthma Info
    • Asthma Info
    • Allergic Rhinitis
    • Allergic Triggers
  • Blog
  • Media
  • Contact Us

9001 Wilshire Blvd. Suite 204
Beverly Hills, CA 90211
Phone: 310-282-8822

16260 Ventura Blvd., Suite 140
Encino, CA 91436
Phone: 818-528-7776

June 30, 2015 by Alan Khadavi

Potential new Nasal Polyps Treatment option

Chronic rhinosinusitis is a common upper airway disease that affects 5%-16% of the population worldwide.  It is characterized by inflammation of the sinuses for at least 12 weeks despite medical treatment.  Nasal polyps frequently accompany chronic sinusitis and their occurrence indicates a serious disease with a potential for a relapse.  Nasal polyps is a frustrating disease with frequent recurrence after removal.  Besides surgery, nasal polyps treatment is not very successful.  Many allergy doctors will start a patient with nasal polyps on Nasonex and/or Singulair which have helped some patients.  Samter’s Triad consist of asthma, nasal polyps and aspirin allergy, some patients undergo successful aspirin desensitization for treatment of their nasal polyps and asthma.

A novel nasal polyps treatment was studied by scientists in Korea.  This nasal polyps potential treatment involves blocking of an IL-25 protein intranasally.  IL-25 has been shown to be responsible for the production of the so called allergy proteins or  TH 2 cytokines.  They consist of IL-4, IL-5, IL-13 and they also help produce eosinophils.  This IL-25 cytokine can be a crucial role in nasal polyp formation.  The study showed that IL-25 expression was increased in nasal polyps and it correlated with increased inflammation.  Neutralizing IL-25 reduced nasal polyp growth in animals and this might represent a new nasal polyps treatment option in the future.

Many patients with nasal polyps are frustrated because there are no good nasal polyps treatment options.  Patients will go under surgery and have them removed, but they can constantly grow back and have to go back for surgery again after a few years.  This potential nasal polyps treatment option will have to be studied in the future.  IL-25 is one of the cytokines responsible for growth of nasal polyps.  Blocking IL-25 may prevent them from growing again.  It is too early to be asking your allergy doctor for this treatment if you have nasal polyps, but it is a positive sign that new nasal polyps treatment options are being investigated and studied.  Hopefully not in the far distant future we will have nasal polyps treatments besides surgery, Nasonex and Singulair.

Currently, Lebrikizumab is being studied and it may be able to get an indication for nasal polyps, in addition to Dupilumab.

Filed Under: Allergy Medicine, Blog, Sinus

alan-khadavi
Dr. Alan Khadavi
Allergy & Asthma Specialist

Latest Posts

May 24, 2022

Lirentelimab study for Chronic Urticaria (Hives)

lirentelimab

May 24, 2022

Dupixent for EoE (Eosinophilic Esophagitis); FDA approved and New Dosing

dupixent for eoe

April 30, 2022

What are the best foods for Asthma?

best foods for asthma

April 26, 2022

Best Nasal Polyps Treatment

best nasal polyps treatment

April 19, 2022

Fasenra for Nasal Polyps, a new treatment option

fasenra for nasal polyps

April 19, 2022

Asivatrep a new topical treatment for Eczema

asivatrep cream

April 3, 2022

Kiwi Allergy can come in many flavors

Kiwi allergy

March 15, 2022

Ana o 3 IgE in diagnosing Cashew Nut Allergy

Ana o 3

March 13, 2022

Does Expired Albuterol work?

expired albuterol

March 8, 2022

Itepekimab in Asthma and COPD

itepekimab for asthma

Read More Posts...

Follow Us…

© 2022 Allergy Los Angeles. All Rights Reserved · Log in · Return to top of page